Current status of functional imaging in neuroblastoma, pheochromocytoma, and paraganglioma diseaseAktueller Stellenwert der funktionellen Bildgebung beim Neuroblastom, Phäochromozytom und Paragangliom

被引：0
作者：
Alexander Stephan Kroiss
机构：
[1] Medical University Innsbruck,Department of Nuclear Medicine
来源：
Wiener Medizinische Wochenschrift | 2019年 / 169卷
关键词：
Glomus tumor; neuroendocrine tumors; PET; CT; MR; Glomustumor; Neuroendokrine Tumoren; PET; CT; MR;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Diagnostic imaging plays an important role in the detection of paraganglioma (PGL), pheochromocytoma (PCC), and neuroblastoma (NB). Anatomic imaging, for example CT or MRI, offers high sensitivity in these neuroendocrine tumors (NET) but only moderate specificity, often associated with difficulties in clearly distinguishing between NET and non-NET. Functional imaging, as in the use of different radioisotopes, is indispensable in oncological imaging. The introduction of PET and PET/CT, respectively, led to a dramatic improvement in both malignant and non-malignant PGL, PCC, and NB, assessing the exact tumor extent. This review gives an overview of functional and anatomical imaging in PGL, PCC, and NB.
引用
收藏
页码：25 / 32
页数：7
相关论文
共 137 条
[11]  
Sisson JC(2009)Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma J Clin Oncol 27 5343-5349
[12]  
Shulkin BL(1996)In vivo demonstration of enzyme activity in endocrine pancreatic tumors: decarboxylation of carbon-11-DOPA to carbon-11-dopamine J Nucl Med 37 32-37
[13]  
Hoefnagel CA(2012)Diagnostic performance of 18F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis Eur J Nucl Med Mol Imaging 39 1144-1153
[14]  
Rufini V(2017)Compared to 123I-MIBG SPECT/CT, 18F-DOPA PET/CT provides accurate tumor extent in patients with extra-adrenal paraganglioma Ann Nucl Med 31 357-365
[15]  
Treglia G(2012)Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study Eur J Nucl Med Mol Imaging 39 57-71
[16]  
Perotti G(2007)68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT J Nucl Med 48 508-518
[17]  
Giordano A(2013)68Ga-DOTA-TOC uptake in neuroendocrine tumour and healthy tissue: differentiation of physiological uptake and pathological processes in PET/CT Eur J Nucl Med Mol Imaging 40 514-523
[18]  
Hoegerle S(2017)Comparison of the Clin Nucl Med 42 525-529
[19]  
Nitzsche E(2011)Ga-DOTATATA PET/CT, FDG PET/CT, and MIBG SPECT/CT in the Evaluation of Suspected Primary Pheochromocytomas and Paragangliomas Eur J Nucl Med Mol Imaging 38 865-873
[20]  
Altehoefer C(2015)Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine Eur J Nucl Med Mol Imaging 42 33-41
12345678910